Our laboratory’s primary interest lies in unraveling the molecular pathogenesis of human cancer, with a focus on discovery of novel therapeutic targets in chemoresistant human cancers. Our approach combines analysis of primary patient samples with functional genetics in the zebrafish model system, leveraging the zebrafish models of high-risk T-cell acute lymphoblastic leukemia and of sarcomas we have recently developed.